Minimal requirement for induction of natural cytotoxicity and intersection of activation signals by inhibitory receptors. Blood 13 — Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion.
Blood 1 — J Immunol 10 — J Exp Med 4 — Natural killer cell cytotoxicity: how do they pull the trigger? Immunology 1 :7— CDa as a functional marker for the identification of natural killer cell activity.
J Immunol Methods 1—2 — Granzymes are essential for natural killer cell-mediated and perf-facilitated tumor control. Eur J Immunol 32 10 —7. Perforin and interferon-gamma activities independently control tumor initiation, growth, and metastasis.
Blood 97 1 —7. Perforin dependence of natural killer cell-mediated tumor control in vivo. Eur J Immunol 25 12 —6. Sonar S, Lal G. Thorburn A. Death receptor-induced cell killing. Cell Signal 16 2 — A central role for death receptor-mediated apoptosis in the rejection of tumors by NK cells.
Critical role for tumor necrosis factor-related apoptosis-inducing ligand in immune surveillance against tumor development. J Exp Med 2 —9. Differential antitumor effects of administration of recombinant IL or recombinant IL are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectively.
NK cell-derived exosomes from NK cells previously exposed to neuroblastoma cells augment the antitumor activity of cytokine-activated NK cells. J Immunother 40 7 — Immune surveillance properties of human NK cell-derived exosomes. J Immunol 6 — Human natural killer cells produce abundant macrophage inflammatory protein-1 alpha in response to monocyte-derived cytokines. J Clin Invest 97 12 —7. Natural killer cells produce T cell-recruiting chemokines in response to antibody-coated tumor cells.
Cancer Res 66 1 — Regulation of human NK-cell cytokine and chemokine production by target cell recognition. Blood 11 — Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice.
Intratumoral natural killer cells show reduced effector and cytolytic properties and control the differentiation of effector Th1 cells. Oncoimmunology 5 12 :e Cutting edge: priming of NK cells by IL Eur J Immunol 29 9 — Interleukin and the costimulatory molecule B have a synergistic anti-tumor effect on murine melanoma; implication of combined immunotherapy for poorly immunogenic malignancy.
J Invest Dermatol 5 — Cancer Immunol Immunother 57 10 — Tolerance and alloreactivity of the Ly49D subset of murine NK cells. Function of NKG2D in natural killer cell-mediated rejection of mouse bone marrow grafts. Nat Immunol 6 9 — Champsaur M, Lanier LL. Effect of NKG2D ligand expression on host immune responses. Immunol Rev 1 — Science — A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules.
Gasser S, Raulet DH. Activation and self-tolerance of natural killer cells. Natural killer cell tolerance in mice with mosaic expression of major histocompatibility complex class I transgene. Licensing of natural killer cells by host major histocompatibility complex class I molecules. NK cell education: not an on-off switch but a tunable rheostat. Trends Immunol 30 4 —9. Identification of human memory-like NK cells.
Curr Protoc Cytom Nat Immunol 11 12 — Natural killer cell-mediated contact sensitivity develops rapidly and depends on interferon-alpha, interferon-gamma and interleukin Immunology 1 — Specific and nonspecific NK cell activation during virus infection. Nat Immunol 2 10 —6. Murine NK cell intrinsic cytokine-induced memory-like responses are maintained following homeostatic proliferation.
J Immunol 9 — Cytokine activation induces human memory-like NK cells. Blood 24 — Leukemia 30 2 — J Exp Med 13 — Oncoimmunology 5 9 :e Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia. Sci Transl Med 8 ra NK cells and T cells cooperate during the clinical course of colorectal cancer. Oncoimmunology 3 8 :e NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma.
Cancer immunoediting by the innate immune system in the absence of adaptive immunity. NKG2D function protects the host from tumor initiation. Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma.
J Exp Med 5 — The critical role of the tumor microenvironment in shaping natural killer cell-mediated anti-tumor immunity. Melanoma cells inhibit natural killer cell function by modulating the expression of activating receptors and cytolytic activity.
Cancer Res 72 6 — Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity. Clin Immunol 3 — Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-beta 1.
J Immunol 1 —9. Myeloid expression of adenosine A2A receptor suppresses T and NK cell responses in the solid tumor microenvironment. Cancer Res 74 24 —9. Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N Engl J Med 23 — Adoptive transfer of autologous natural killer cells leads to high levels of circulating natural killer cells but does not mediate tumor regression. Clin Cancer Res 17 19 — Phase I clinical trial of autologous NK cell therapy using novel expansion method in patients with advanced digestive cancer.
J Transl Med Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer. Blood 8 —7. Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients.
Blood 12 —9. Antigen presenting cell-mediated expansion of human umbilical cord blood yields log-scale expansion of natural killer cells with anti-myeloma activity.
PLoS One 8 10 :e High-efficiency lysis of cervical cancer by allogeneic NK cells derived from umbilical cord progenitors is independent of HLA status. Cancer Immunol Immunother 66 1 — A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer. Cytotherapy 13 1 — IL enhances natural killer cell response to cetuximab-coated pancreatic tumor cells. Clin Cancer Res 23 2 — Oncol Rep 37 3 — Nat Immunol 15 8 — Johansson, M.
Natural killer cell tolerance in mice with mosaic expression of major histocompatibility complex class I transgene. Licensing of natural killer cells by host major histocompatibility complex class I molecules.
Yu, J. Fernandez, N. A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. Raulet, D. Self-tolerance of natural killer cells. Stewart, C. Strategies of NK cell recognition and their roles in tumor immunosurveillance. Kitamura, D. Diefenbach, A. Cerwenka, A. Ectopic expression of retinoic acid early inducible-1 gene RAE-1 permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo.
USA 98 , — Kelly, J. Induction of tumor-specific T cell memory by NK cell—mediated tumor rejection. NKG2D function protects the host from tumor initiation. Street, S. Orange, J. Human natural killer cell deficiencies.
Allergy Clin. Imai, K. Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an year follow-up study of a general population. Lancet , — Ruggeri, L. Allogeneic hematopoietic transplantation and natural killer cell recognition of missing self.
Bignon, J. KIR matching in hematopoietic stem cell transplantation. Koh, C. Augmentation of antitumor effects by NK cell inhibitory receptor blockade in vitro and in vivo. Blood 97 , — Ljunggren, H. Prospects for the use of NK cells in immunotherapy of human cancer. McKenna, D. Good manufacturing practices production of natural killer cells for immunotherapy: a six-year single-institution experience.
Transfusion 47 , — Miller, J. Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer. Lee, S. Keeping NK cells in highly regulated antiviral warfare.
Scalzo, A. The interplay between host and viral factors in shaping the outcome of cytomegalovirus infection. Cell Biol. Smith, H. Recognition of a virus-encoded ligand by a natural killer cell activation receptor. USA 99 , — Arase, H. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Desrosiers, M. Epistasis between mouse Klra and major histocompatibility complex class I loci is associated with a new mechanism of natural killer cell—mediated innate resistance to cytomegalovirus infection.
Dalod, M. Biron, C. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Vidal, S. NK cell recognition of mouse cytomegalovirus-infected cells. Voigt, S. Fischer, A. Human primary immunodeficiency diseases.
Immunity 27 , — Interplay of natural killer cells and their receptors with the adaptive immune response. Paya, C. Role of natural killer cells as immune effectors in encephalitis and demyelination induced by Theiler's virus. Fairweather, D. From infection to autoimmunity. Robbins, S. Natural killer cells promote early CD8 T cell responses against cytomegalovirus.
PLoS Pathog. Perforin and granzymes have distinct roles in defensive immunity and immunopathology. Janka, G. Hemophagocytic syndromes. Blood Rev. Jordan, M. Crozat, K. Jinx , an MCMV susceptibility phenotype caused by disruption of Unc13d : a mouse model of type 3 familial hemophagocytic lymphohistiocytosis. Nedvetzki, S. Reciprocal regulation of natural killer cells and macrophages associated with distinct immune synapses.
Moretta, L. Effector and regulatory events during natural killer-dendritic cell interactions. Degli-Esposti, M. Close encounters of different kinds: dendritic cells and NK cells take centre stage. Piccioli, D. Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells. Yu, G. NK cells promote transplant tolerance by killing donor antigen-presenting cells.
Wu, H. Martin-Fontecha, A. Morandi, B. Lu, L. Takeda, K. Johansson, S. NK cells: elusive players in autoimmunity. Yoneda, O. Fractalkine-mediated endothelial cell injury by NK cells. Bolovan-Fritts, C. Endothelial damage from cytomegalovirus-specific host immune response can be prevented by targeted disruption of fractalkine-CX3CR1 interaction. Rieben, R.
Xenograft rejection: IgG1, complement and NK cells team up to activate and destroy the endothelium. Managing Cancer Care. Finding Health Care Services. Advance Directives. Using Trusted Resources. Coronavirus Information for Patients. Clinical Trials during Coronavirus. Adolescents and Young Adults with Cancer. Emotional Support for Young People with Cancer.
Cancers by Body Location. Late Effects of Childhood Cancer Treatment. Pediatric Supportive Care. Rare Cancers of Childhood Treatment. Childhood Cancer Genomics. Study Findings. Metastatic Cancer Research. Intramural Research. Extramural Research. Cancer Research Workforce. Partners in Cancer Research. What Are Cancer Research Studies. Research Studies. Get Involved. Cancer Biology Research. Cancer Genomics Research.
Research on Causes of Cancer. Cancer Prevention Research. Cancer Treatment Research. Cancer Health Disparities. Childhood Cancers Research. Global Cancer Research. Cancer Research Infrastructure.
Clinical Trials. J Cancer — IL from conventional NK cells is epithelial regenerative and inflammation protective during influenza infection. Mucosal Immunol — Natural killer NK cells in antibacterial innate immunity: angels or devils?
Mol Med — The natural killer cell interferon-gamma response to bacteria is diminished in untreated HIV-1 infection and defects persist despite viral suppression. J Acquir Immune Defic Syndr — Natural killer cells and antifungal host response.
Clin Vaccine Immunol —8. NK cells use perforin rather than granulysin for anticryptococcal activity. Human natural killer cells acting as phagocytes against Candida albicans and mounting an inflammatory response that modulates neutrophil antifungal activity.
J Infect Dis — IL regulates systemic fungal immunity by controlling the functional competence of NK cells. Pathogen evasion strategies for the major histocompatibility complex class I assembly pathway. Mammalian non-classical major histocompatibility complex I and its receptors: important contexts of gene, evolution, and immunity.
Indian J Hum Genet — Khanna R. Tumour surveillance: missing peptides and MHC molecules. Immunol Cell Biol —6. Present yourself! Schwartz RH. Historical overview of immunological tolerance. Cold Spring Harb Perspect Biol 4:a The role of natural killer cells in resistance to the intracellular bacterium Listeria monocytogenes in rats. Scand J Immunol — Unanue ER. Studies in listeriosis show the strong symbiosis between the innate cellular system and the T-cell response.
Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells. Hepatology —9. Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1. Elucidating the mechanisms of influenza virus recognition by Ncr1. PLoS One 7:e Structural elucidation of the m mouse cytomegalovirus ligand for Ly49 natural killer cell receptors.
Gain of virulence caused by loss of a gene in murine cytomegalovirus. Ly49h is necessary for genetic resistance to murine cytomegalovirus. Curr Opin Immunol —9. Human cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicity. Ljunggren HG, Karre K. Immunol Today — Immune evasion of natural killer cells by viruses. Curr Opin Immunol —8. Adaptive immune features of natural killer cells. T cell- and B cell-independent adaptive immunity mediated by natural killer cells.
Immune memory redefined: characterizing the longevity of natural killer cells. Kamimura Y, Lanier LL. Homeostatic control of memory cell progenitors in the natural killer cell lineage. Natural killer cell memory. Nabekura T, Lanier LL. Tracking the fate of antigen-specific versus cytokine-activated natural killer cells after cytomegalovirus infection.
PLoS Pathog 7:e Haematologica — NK cells generate memory-type responses to human cytomegalovirus-infected fibroblasts. Activation of natural killer cells during microbial infections. Chowdhury D, Lieberman J. Death by a thousand cuts: granzyme pathways of programmed cell death. Cytotoxic cells kill intracellular bacteria through granulysin-mediated delivery of granzymes. Cell Granzyme B-induced mitochondrial ROS are required for apoptosis. Granzyme B disrupts central metabolism and protein synthesis in bacteria to promote an immune cell death program.
Role of NK1. Thale C, Kiderlen AF. Sources of interferon-gamma IFN-gamma in early immune response to Listeria monocytogenes. Immunobiology — Activation of human NK cells by staphylococci and lactobacilli requires cell contact-dependent costimulation by autologous monocytes. Clin Diagn Lab Immunol — NK cell-derived IFN-gamma differentially regulates innate resistance and neutrophil response in T cell-deficient hosts infected with Mycobacterium tuberculosis. Functional characterization of human natural killer cells responding to Mycobacterium bovis bacille Calmette-Guerin.
PLoS One 4:e Humann J, Lenz LL. Activation of naive NK cells in response to Listeria monocytogenes requires IL and contact with infected dendritic cells. Mechanisms of NK cell-macrophage Bacillus anthracis crosstalk: a balance between stimulation by spores and differential disruption by toxins. PLoS Pathog 8:e Zwirner NW, Ziblat A. Host resistance directed selectively against Hdeficient lymphoma variants.
Analysis of the mechanism. Depletion of natural killer cells in mice by monoclonal antibody to NK Reduction in host defense against malignancy without loss of cellular or humoral immunity. EMT and tumor metastasis. Clin Transl Med The HLA crossroad in tumor immunology. Hum Immunol — Natural killer cells and viral infections. Curr Opin Immunol — Diefenbach A, Raulet DH. Strategies for target cell recognition by natural killer cells.
Raulet DH. Interplay of natural killer cells and their receptors with the adaptive immune response. Waldhauer I, Steinle A. NK cells and cancer immunosurveillance. Oncogene — Malarkannan S. Semin Immunol — Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an year follow-up study of a general population.
Lancet —9. The prognostic significance of intratumoral natural killer cells in patients with colorectal carcinoma. Cancer —8. Prognostic value of intratumoral natural killer cells in gastric carcinoma.
Cancer — Prognostic significance of tumor infiltrating natural killer cells subset CD57 in patients with squamous cell lung cancer. Lung Cancer —8. Recognition of adult and pediatric acute lymphoblastic leukemia blasts by natural killer cells.
Exploitation of natural killer cells for the treatment of acute leukemia. NK cell therapy for hematologic malignancies. Present and future of allogeneic natural killer cell therapy. Cellular immunotherapy and autologous transplantation for hematologic malignancy. Adoptive transfer of autologous natural killer cells leads to high levels of circulating natural killer cells but does not mediate tumor regression. Clin Cancer Res 17 19 — Clin Cancer Res 24 8 — NK cell therapy after hematopoietic stem cell transplantation: can we improve anti-tumor effect?
Int J Hematol —6. Bone Marrow Transplant —8. Allogeneic stem cell transplantation in a patient with relapsed Ewing sarcoma. Pediatr Blood Cancer —4. Allogeneic and autologous stem-cell transplantation in advanced Ewing tumors. Stem-cell transplant programs at Dusseldorf university medical center, Germany and St.
Anna Kinderspital, Vienna, Austria. Ann Oncol — A successful case of allogeneic bone marrow transplantation for osteosarcoma with multiple metastases of lung and bone. Bone Marrow Transplant —6. Regression of metastatic osteosarcoma following non-myeloablative stem cell transplantation. A case report. Haematologica ECR Allogeneic bone marrow transplant for refractory mediastinal germ cell tumour: possible evidence of graft-versus-tumour effect.
Intern Med J —9. Poor outcome of two children with relapsed state stage IV alveolar rhabdomyosarcoma after allogeneic stem cell transplantation. Pediatr Hematol Oncol — Regression of refractory rhabdomyosarcoma after allogeneic stem-cell transplantation. Pediatr Hematol Oncol —5. Allogeneic hematopoietic stem cell transplantation against recurrent rhabdomyosarcoma.
J Pediatr Hematol Oncol e35—8. Reduced-intensity allogeneic stem cell transplantation for children with neuroblastoma who failed tandem autologous stem cell transplantation. Pediatr Blood Cancer —5. Engraftment of unrelated cord blood after reduced-intensity conditioning regimen in children with refractory neuroblastoma: a feasibility trial.
Bone Marrow Transplant —7. Graft versus neuroblastoma reaction is efficiently elicited by allogeneic bone marrow transplantation through cytolytic activity in the absence of GVHD. Cancer Immunol Immunother — Matched unrelated umbilical cord blood transplantation for a patient with chemotherapy resistant Wilms tumor.
Successful treatment with reduced-intensity stem cell transplantation in a case of relapsed refractory central nervous system lymphoma.
Ann Hematol —3. Stem Cell Reports — NK cell-based immunotherapy for cancer. Diversification and functional specialization of human NK cell subsets. Curr Top Microbiol Immunol — Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo. Nat Med — Moretta A. Natural killer cells and dendritic cells: rendezvous in abused tissues. Eur Cytokine Netw — NK cell and DC interactions. Whatever turns you on: accessory-cell-dependent activation of NK cells by pathogens.
Interplay of NK cells and monocytes in vascular inflammation and myocardial infarction. Front Physiol The role of natural killer cells in sepsis. Bosmann M, Ward PA. Modulation of inflammation by interleukin Immunoregulatory role of NK cells in tissue inflammation and regeneration. Transforming growth factor-beta controls T helper type 1 cell development through regulation of natural killer cell interferon-gamma.
Nat Immunol —7. NK-cell-mediated killing of target cells triggers robust antigen-specific T-cell-mediated and humoral responses. Receptors and counterreceptors involved in NK-B cell interactions. Pallmer K, Oxenius A. Recognition and regulation of T cells by NK cells. IL imparts immunoregulatory function to human NK cell subsets. PLoS One 6:e Regulatory functions of natural killer cells in multiple sclerosis. Unexpected role for granzyme K in CD56bright NK cell-mediated immunoregulation of multiple sclerosis.
0コメント